IN2012DN00791A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00791A IN2012DN00791A IN791DEN2012A IN2012DN00791A IN 2012DN00791 A IN2012DN00791 A IN 2012DN00791A IN 791DEN2012 A IN791DEN2012 A IN 791DEN2012A IN 2012DN00791 A IN2012DN00791 A IN 2012DN00791A
- Authority
- IN
- India
- Prior art keywords
- streptococcus pneumoniae
- prophylactically
- elderly
- antigens
- young
- Prior art date
Links
- 241000193998 Streptococcus pneumoniae Species 0.000 abstract 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 abstract 2
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22154109P | 2009-06-29 | 2009-06-29 | |
US24059809P | 2009-09-08 | 2009-09-08 | |
US24061609P | 2009-09-08 | 2009-09-08 | |
US31626710P | 2010-03-22 | 2010-03-22 | |
PCT/US2010/040406 WO2011008548A1 (en) | 2009-06-29 | 2010-06-29 | Vaccines and compositions against streptococcus pneumoniae |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00791A true IN2012DN00791A (en) | 2015-06-26 |
Family
ID=43449681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN791DEN2012 IN2012DN00791A (en) | 2009-06-29 | 2010-06-29 |
Country Status (15)
Country | Link |
---|---|
US (2) | US10105412B2 (en) |
EP (1) | EP2448592B1 (en) |
JP (1) | JP5931724B2 (en) |
KR (1) | KR101748453B1 (en) |
CN (2) | CN102548572A (en) |
AU (1) | AU2010273708B2 (en) |
BR (1) | BRPI1011919A2 (en) |
CA (1) | CA2803061A1 (en) |
IL (1) | IL217166A0 (en) |
IN (1) | IN2012DN00791A (en) |
MX (1) | MX2012000158A (en) |
NZ (1) | NZ597858A (en) |
RU (1) | RU2580299C2 (en) |
SG (2) | SG10201403702SA (en) |
WO (1) | WO2011008548A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011008548A1 (en) | 2009-06-29 | 2011-01-20 | Genocea Biosciences, Inc. | Vaccines and compositions against streptococcus pneumoniae |
WO2011112906A2 (en) | 2010-03-12 | 2011-09-15 | Children's Medical Center Corporation | Novel immunogens and methods for discovery and screening thereof |
CA2822715C (en) * | 2010-12-21 | 2019-04-30 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Determination of the efficacy of an anti-mycobacterial vaccination |
WO2012100234A1 (en) | 2011-01-20 | 2012-07-26 | Genocea Biosciences, Inc. | Vaccines and compositions against streptococcus pneumoniae |
UY33939A (en) * | 2011-03-09 | 2012-09-28 | Glaxosmithkline Llc | INHIBITORS OF THE PEPTIDE DESFORMILASA |
ES2864764T3 (en) | 2011-05-11 | 2021-10-14 | Childrens Medical Center | Immunogenic composition presenting multiple antigens, and its methods and uses |
EP2804627B1 (en) * | 2012-01-20 | 2019-08-14 | Genocea Biosciences Inc. | Fused antigen vaccines and compositions against streptococcus pneumoniae |
WO2014018904A1 (en) * | 2012-07-26 | 2014-01-30 | Genocea Biosciences, Inc. | Fused antigen vaccines and compositions against streptococcus pneumoniae |
ES2959258T3 (en) | 2013-02-07 | 2024-02-22 | Childrens Medical Center | Protein antigens that provide protection against pneumococcal colonization and/or disease |
US20150079132A1 (en) * | 2013-09-17 | 2015-03-19 | Path | Evoking protection against streptotoccus pneumoniae incorporating b-cell and t-cell pneumococcal protein antigens and pneumococcal polysaccharides delivered concomitantly |
EP3131579A4 (en) * | 2014-04-18 | 2017-10-25 | The Children's Medical Center Corporation | Vaccine adjuvant compositions |
US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
HRP20220573T1 (en) * | 2017-01-20 | 2022-06-10 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
CN110730670A (en) | 2017-03-28 | 2020-01-24 | 儿童医疗中心有限公司 | Multi-antigen presentation system (MAPS) -based staphylococcus aureus vaccines, immunogenic compositions, and uses thereof |
ES2967001T3 (en) | 2017-06-23 | 2024-04-25 | Affinivax Inc | Immunogenic compositions |
BR112021004193A2 (en) | 2018-09-12 | 2021-05-25 | Affinivax, Inc. | multivalent pneumococcal vaccines |
RU2728938C1 (en) * | 2020-05-06 | 2020-08-03 | Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) | Use of dalargin for production of drug preparations for preventing pneumonia |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2059692C (en) * | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
US5371197A (en) * | 1991-09-24 | 1994-12-06 | Merck & Co., Inc. | Protein-dimeric polysaccharide conjugate vaccine |
US5505947A (en) | 1994-05-27 | 1996-04-09 | The University Of North Carolina At Chapel Hill | Attenuating mutations in Venezuelan Equine Encephalitis virus |
JP2000511769A (en) | 1996-04-02 | 2000-09-12 | スミスクライン・ビーチャム・コーポレイション | New compound |
DE69737125T3 (en) * | 1996-10-31 | 2015-02-26 | Human Genome Sciences, Inc. | Streptococcus pneumoniae antigens and vaccines |
CN1268178A (en) | 1997-05-06 | 2000-09-27 | 人体基因组科学有限公司 | i (Enterococcus faecalis) polynucleotides and polypeptides |
CA2294568A1 (en) | 1997-06-20 | 1998-12-30 | Human Genome Sciences, Inc. | Lyme disease vaccines |
US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
US5882885A (en) * | 1997-07-17 | 1999-03-16 | Smithkline Beecham Corporation | Glycogen phosphorylase |
US5994101A (en) * | 1997-07-18 | 1999-11-30 | Smithkline Beecham Corporation | DNA encoding gidA1 polypeptides |
US6617156B1 (en) * | 1997-08-15 | 2003-09-09 | Lynn A. Doucette-Stamm | Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics |
US6248558B1 (en) | 1998-03-31 | 2001-06-19 | Vanderbilt University | Sequence and method for genetic engineering of proteins with cell membrane translocating activity |
EP1144640A3 (en) | 1998-07-27 | 2001-11-28 | Microbial Technics Limited | Nucleic acids and proteins from streptococcus pneumoniae |
EP1185297B1 (en) | 1999-06-10 | 2006-05-10 | MedImmune, Inc. | Streptococcus pneumoniae proteins and vaccines |
US6887480B1 (en) * | 1999-06-10 | 2005-05-03 | Medimmune, Inc. | Streptococcus pneumoniae proteins and vaccines |
HUP0203880A2 (en) * | 1999-12-23 | 2003-03-28 | Vmax Limited | Streptococcus pyogenes virulence genes and proteins and their use |
US6783939B2 (en) * | 2000-07-07 | 2004-08-31 | Alphavax, Inc. | Alphavirus vectors and virosomes with modified HIV genes for use in vaccines |
EP2189473A3 (en) * | 2000-10-27 | 2010-08-11 | Novartis Vaccines and Diagnostics S.r.l. | Nucleic and proteins from streptococcus groups A & B |
GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
EP2261241A1 (en) | 2001-04-16 | 2010-12-15 | Wyeth Holdings Corporation | Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
US20040029129A1 (en) * | 2001-10-25 | 2004-02-12 | Liangsu Wang | Identification of essential genes in microorganisms |
US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
EP2275121B1 (en) * | 2002-04-02 | 2013-06-12 | Ben Gurion University Of The Negev Research And Development Authority | Protein-based streptococcus pneumoniae vaccines |
US20090252756A1 (en) * | 2002-04-02 | 2009-10-08 | Yaffa Mizrachi-Nebenzahl | Protein-based streptococcus pneumoniae vaccines |
US20070053924A1 (en) * | 2002-08-26 | 2007-03-08 | Herve Tettelin | Conserved and specific streptococcal genomes |
WO2004020609A2 (en) | 2002-08-30 | 2004-03-11 | Tufts University | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
CA2522238A1 (en) | 2003-04-15 | 2004-10-28 | Intercell Ag | S. pneumoniae antigens |
GB0318688D0 (en) * | 2003-08-08 | 2003-09-10 | Chiron Srl | Streptococcus pneumoniae knockout mutants |
MX2007007033A (en) | 2004-12-22 | 2007-08-03 | Novartis Vaccines & Diagnostic | Group b streptococcus. |
WO2006084466A2 (en) * | 2005-02-11 | 2006-08-17 | Ace Biosciences A/S | Surface-located streptococcus pneumoniae polypeptides |
US20110177960A1 (en) * | 2006-03-10 | 2011-07-21 | Ellen Murphy | Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae |
PT2054431E (en) * | 2006-06-09 | 2011-11-03 | Novartis Ag | Conformers of bacterial adhesins |
GB0700136D0 (en) * | 2007-01-04 | 2007-02-14 | Glaxosmithkline Biolog Sa | Process for manufacturing vaccines |
WO2008119358A2 (en) | 2007-03-30 | 2008-10-09 | Ace Biosciences A/S | Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions |
WO2009011971A2 (en) | 2007-05-18 | 2009-01-22 | The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health And Human Services, Centers For Disease Control And Prevention | Primers and probes for the detection of streptococcus pneumoniae |
CN101848929A (en) | 2007-05-25 | 2010-09-29 | 诺华有限公司 | Streptococcus pneumoniae pilus antigens |
US20100247547A1 (en) * | 2007-05-29 | 2010-09-30 | Chen Dong | Modulation of the th-17 cell mediated immune responses |
GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
US20100278819A1 (en) * | 2007-09-14 | 2010-11-04 | Katholieke Universiteit Leuven | Streptococcus pneumoniae vaccines |
US7833776B2 (en) * | 2007-12-12 | 2010-11-16 | National Health Research Institutes | Lipidating sequences and use thereof for producing lipidated proteins in E. coli |
US8466259B2 (en) * | 2007-12-07 | 2013-06-18 | National Health Research Institutes | Adjuvants |
WO2009114207A2 (en) * | 2008-03-14 | 2009-09-17 | Sanofi Pasteur Biologics Co. | Replication-defective flavivirus vaccines and vaccine vectors |
AU2009266924B2 (en) | 2008-07-01 | 2015-12-10 | Genocea Biosciences, Inc. | Antigen screening system |
KR20110091560A (en) | 2008-12-03 | 2011-08-11 | 프로테아 벡신 테크놀로지스 엘티디. | Glutamyl trna synthetase (gts) fragments |
US8287880B2 (en) * | 2009-06-02 | 2012-10-16 | National Health Research Institutes | Lipidated vaccine against dengue virus infection |
TWI409275B (en) * | 2009-06-22 | 2013-09-21 | Nat Health Research Institutes | Lipidated tumor-associated antigens and immunotherapeutic compositions |
US20120100172A1 (en) * | 2009-06-25 | 2012-04-26 | Michael Tal | Immunogenic streptococcus pneumoniae peptides and peptide-multimers |
WO2011008548A1 (en) | 2009-06-29 | 2011-01-20 | Genocea Biosciences, Inc. | Vaccines and compositions against streptococcus pneumoniae |
WO2011064781A1 (en) | 2009-11-30 | 2011-06-03 | Ben-Gurion University Of The Negev Research And Development Authority | S. pneumoniae adhesins |
WO2011067758A2 (en) | 2009-12-02 | 2011-06-09 | Protea Vaccine Technologies Ltd. | Immunogenic fragments and multimers from streptococcus pneumoniae proteins |
JP5065434B2 (en) * | 2010-04-06 | 2012-10-31 | 株式会社日立製作所 | Management method and management apparatus |
WO2011128892A2 (en) | 2010-04-12 | 2011-10-20 | Protea Vaccine Technologies Ltd. | Modified forms of pneumococcal surface immunogenic protein b (psipb) |
US20110283062A1 (en) * | 2010-05-14 | 2011-11-17 | Hitachi, Ltd. | Storage apparatus and data retaining method for storage apparatus |
WO2012100234A1 (en) * | 2011-01-20 | 2012-07-26 | Genocea Biosciences, Inc. | Vaccines and compositions against streptococcus pneumoniae |
-
2010
- 2010-06-29 WO PCT/US2010/040406 patent/WO2011008548A1/en active Application Filing
- 2010-06-29 US US12/826,084 patent/US10105412B2/en active Active
- 2010-06-29 CN CN2010800388746A patent/CN102548572A/en active Pending
- 2010-06-29 CN CN201710169055.9A patent/CN107126557A/en active Pending
- 2010-06-29 IN IN791DEN2012 patent/IN2012DN00791A/en unknown
- 2010-06-29 CA CA2803061A patent/CA2803061A1/en not_active Abandoned
- 2010-06-29 SG SG10201403702SA patent/SG10201403702SA/en unknown
- 2010-06-29 RU RU2011153032/15A patent/RU2580299C2/en not_active IP Right Cessation
- 2010-06-29 SG SG2011096898A patent/SG177402A1/en unknown
- 2010-06-29 JP JP2012518575A patent/JP5931724B2/en not_active Expired - Fee Related
- 2010-06-29 BR BRPI1011919A patent/BRPI1011919A2/en not_active IP Right Cessation
- 2010-06-29 NZ NZ597858A patent/NZ597858A/en not_active IP Right Cessation
- 2010-06-29 MX MX2012000158A patent/MX2012000158A/en unknown
- 2010-06-29 AU AU2010273708A patent/AU2010273708B2/en not_active Ceased
- 2010-06-29 KR KR1020127001971A patent/KR101748453B1/en active IP Right Grant
- 2010-06-29 EP EP10800303.9A patent/EP2448592B1/en active Active
-
2011
- 2011-12-22 IL IL217166A patent/IL217166A0/en unknown
-
2018
- 2018-09-17 US US16/133,590 patent/US11207375B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20190298795A1 (en) | 2019-10-03 |
AU2010273708A8 (en) | 2012-06-14 |
EP2448592A1 (en) | 2012-05-09 |
SG10201403702SA (en) | 2014-09-26 |
EP2448592B1 (en) | 2020-06-17 |
WO2011008548A1 (en) | 2011-01-20 |
RU2011153032A (en) | 2013-08-10 |
MX2012000158A (en) | 2012-06-08 |
RU2580299C2 (en) | 2016-04-10 |
WO2011008548A8 (en) | 2012-03-08 |
EP2448592A4 (en) | 2013-04-24 |
AU2010273708B2 (en) | 2015-10-01 |
NZ597858A (en) | 2014-01-31 |
JP2012532134A (en) | 2012-12-13 |
US20110020386A1 (en) | 2011-01-27 |
KR101748453B1 (en) | 2017-06-16 |
CN107126557A (en) | 2017-09-05 |
US10105412B2 (en) | 2018-10-23 |
JP5931724B2 (en) | 2016-06-08 |
CN102548572A (en) | 2012-07-04 |
AU2010273708A1 (en) | 2012-02-23 |
CA2803061A1 (en) | 2011-01-20 |
BRPI1011919A2 (en) | 2017-09-26 |
KR20120093141A (en) | 2012-08-22 |
SG177402A1 (en) | 2012-02-28 |
IL217166A0 (en) | 2012-02-29 |
US11207375B2 (en) | 2021-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN00791A (en) | ||
MY163871A (en) | Vaccines and compositions against streptococcus pneumoniae | |
MX2017009308A (en) | Immunogenic compositions for use in pneumococcal vaccines. | |
IL219876A (en) | Antibody or fragment thereof against human b7-h1, compositions comprising same and use thereof in the preparation of medicaments | |
IL217208A0 (en) | Novel conjugates, preparation thereof, and therapeutic use thereof | |
MX2009011500A (en) | Anti-mdl-1 antibodies. | |
IL211842A (en) | Antibody or human tgfbrii-binding fragment thereof, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for inhibiting angiogenesis | |
MX2016008226A (en) | Prebiotic oral care methods using a saccharide. | |
MX2011007456A (en) | Cna_b domain antigens in vaccines against gram positive bacteria. | |
AP2012006292A0 (en) | Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection. | |
WO2009115509A3 (en) | Antigenic protein fragments of streptococcus pneumoniae | |
IL194353A0 (en) | Lysobactin amides | |
TN2012000217A1 (en) | The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease | |
TR200909786A1 (en) | Effervescent tablet and granule formulation containing cefixime. | |
WO2013109995A3 (en) | Fused antigen vaccines and compositions against streptococcus pneumoniae | |
MX2014006201A (en) | Imatinib solid dosage forms reconstituted just before use. | |
AP2012006128A0 (en) | Formulations and methods employing anhydrous disinfectant. | |
MX2010004734A (en) | Novel antiretroviral combination. | |
MY158116A (en) | Combination vaccine against streptococcus | |
TH117697B (en) | sanitary napkin | |
TH117225B (en) | sanitary napkin | |
IT1395151B1 (en) | DEVICE TO FIND THE PRESENCE OF NON-SELF-SUFFICIENT PEOPLE OR CHILDREN IN BEDS, WHEELCHAIRS, ARMCHAIRS AND THE LIKE. | |
CN302166494S (en) | disinfection cabinet | |
TH107709B (en) | Materials to help clean the mouth and teeth. | |
IL211283A0 (en) | Compositions and use thereof for treating s. pneumoniae infection |